Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Genome Designs Partners with SciDM Group

Published: Thursday, April 26, 2012
Last Updated: Thursday, April 26, 2012
Bookmark and Share
Securing high performance bioinformatics tools for internal pipelines and custom projects.

Genome Designs, Inc. has announced a partnership with SciDM Group, a bioinformatics tools developer.

Genome Designs will be using SciDM Group’s high performance database engine, transcriptomics data processing pipeline, and high throughput sequence comparison technology.

The tools will be used to augment Genome Designs’ existing genome annotation pipelines and to boost custom software development projects for clients.

“SciDM Group strives to provide computational biologists with fast and flexible data management and bioinformatics tools, capable of keeping the pace with the progress of high-throughput data acquisition technologies, for example, with the recent avalanche of sequencing data,” said Denis Kaznadzey, the leader of SciDM Group.

Kaznadzey continued, “Our tools are free, most are open source and available for download from public repositories. However, they require integration with the client’s system. Our partnership with Genome Designs goes beyond just another vendor-client relationship: they are planning to provide installation and integration services for our products”.

SciDM Group’s flagship product, a database management system, is a zero-maintenance object-relational database engine optimized for dealing with extremely large volumes of data.

On typical bioinformatics tasks like sequence assembly and clustering, SciDM Data Manager operates thousands of times faster than conventional database engines, including popular commercial brands.

Other tools by SciDM Group similarly allow considerable performance optimization and subsequent gain in speed: QSimScan (Quick SIMilarity SCANner) performs 5 to 100 times faster than standard NCBI BLAST depending on search parameters, and EST pipeline efficiently converts raw transcriptomics data into normalized gene expression profiles.

“Since our beginning of operation, we have seen a considerable interest in our custom genome annotation and metabolic engineering services. However, our potential clients often needed more than that: we experienced a strong demand for custom software tools,” commented Natalia Alexandrova, CEO of Genome Designs.

Alexandrova continued, “Originally, such projects have been beyond our scope, but our partnership with SciDM Group will allow us to shorten development cycles and deliver robust systems without changing the focus of the company, and to higher customer’s satisfaction”.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Genome Designs Receives Seed Financing and Starts Operation
Company has received seed financing from undisclosed private investors.
Wednesday, February 08, 2012
Scientific News
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
ALS Study Reveals Role of RNA-Binding Proteins
The findings are a significant step forward in validating RNA-based therapy as a treatment for ALS.
New Compound Shows Promise in Treating Multiple Human Cancers
The research presents a new way to efficiently kill these cancerous cells and holds promise for the treatment of all cancers.
Tumor Markers Reveal Lethality Of Bladder Cancers
Researchers found that detection of certain tumor cells in early stage cancers helps identify high-risk cancers.
Lab-on-a-Chip to Help Detect Cancer
In this podcast, we speak to Gustavo Stolovitsky to learn about his career and the work he is doing at IBM Research.
Using CRISPR to Accelerate Search for HIV Cure
Gene-editing platform makes it easier to create HIV-resistant immune cells.
Gene Editing Corrects Sickle Cell Mutation
Researchers demonstrate a potential pathway to developing gene-editing treatments for sickle cell disease.
IU Research Reveals Link between Molecular Mechanisms in Prostate Cancer and Ewing's sarcoma
Researchers at IU have suggested that the molecular mechanism that triggers the rare disease Ewing's sarcoma could act as a potential new direction for the treatment of more than half of patients with prostate cancer.
Driving Mosquito Evolution to Fight Malaria
Researchers propose insect repellent in conjunction with insecticides to extend current insecticide lifetime.
Fighting Cancer with Immune Response
New treatment elicits two-pronged immune response that destroys tumors in mice.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos